Picture of Ardent Health logo

ARDT — Ardent Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareMid CapSuper Stock

Ardent Health Q3 revenue beats analyst estimates

Ardent Health Q3 revenue beats analyst estimates


Overview

  • U.S. hospital operator's Q3 revenue rose 3.1% yr/yr, beating analyst expectations

  • Adjusted EBITDA for Q3 beat analyst expectations

  • Company increased share repurchase authorization by $25 mln


Outlook

  • Company raises 2026 adjusted EBITDA guidance to $500–535 mln from $485–535 mln

  • Company maintains 2026 revenue outlook at $6.4–6.7 bln

  • Company lifts 2026 net income guidance to $132–167 mln from $110–163 mln


Result Drivers

  • COST SAVINGS INITIATIVES - IMPACT program contributed to efficiency gains and improved financial performance

  • VOLUME GROWTH - 2.9% rise in adjusted admissions drove revenue growth


Company press release: ID:nBw8gLDVSa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$1.62 bln

$1.60 bln (11 Analysts)

Q3 EPS

$0.31

Q3 Net Income

$44.52 mln

Q3 Adjusted EBITDA

Beat

$138 mln

$124.18 mln (11 Analysts)


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 5 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Ardent Health Inc is $13.00, about 11% above its November 3 closing price of $11.71

  • The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 10 three months ago


Reuters Recommended Reads

  • Nov 4 - Health insurers, hospitals rally after sweeping midterm win for Democrats

  • Nov 4 - CVS to break up $117 billion business, separating pharmacies from insurance; shares fall

  • Nov 4 - India's Apollo Hospitals posts higher quarterly profit


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Ardent Health

See all news